Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5645
Abstract: The excess mortality observed in Acute Myeloblastic Leukaemia (AML) patients, partly attributed to unequal access to curative treatments, could be linked to care pathways. read more here.
Keywords: influencing access; acute myeloblastic; factors influencing; myeloblastic leukaemia ... See more keywords
Giant cellulitis-like Sweet syndrome as an initial clinical presentation of acute myeloblastic leukemia with t(6;9)(p23;q34): DEK-CAN and internal duplications of FMS-like tyrosine kinase 3
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Hematology"
DOI: 10.1007/s00277-019-03613-1
Abstract: Dear Editor, A 56-year-old female farmer knocked her right knee against the ground and suffered from stinging pain, while she was working in a rice field. The next day, she developed a painful erythematous eruption… read more here.
Keywords: skin lesions; cellulitis; acute myeloblastic; giant cellulitis ... See more keywords
Outcome disparities by insurance type for patients with acute myeloblastic leukemia.
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia research"
DOI: 10.1016/j.leukres.2017.02.001
Abstract: Survival for patients with acute myeloblastic leukemia (AML) has increased during the past two decades. However, socioeconomic disparities may affect survival for some patient populations. We examine survival by insurance type for patients with AML.… read more here.
Keywords: insurance type; patients acute; myeloblastic leukemia; insurance ... See more keywords
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Open"
DOI: 10.1136/bmjopen-2019-029642
Abstract: Introduction Acute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabine with anthracyclines and topoisomerase… read more here.
Keywords: consolidation; trial; acute myeloblastic; natural killer ... See more keywords